Research and Markets: Cytomegalovirus Infection Global Clinical Trials Review, Q1, 2011

DUBLIN--(BUSINESS WIRE)-- Research and Markets(http://www.researchandmarkets.com/research/284b61/cytomegalovirus_in) has announced the addition of GlobalData's new report "Cytomegalovirus Infection Global Clinical Trials Review, Q1, 2011" to their offering.

Our clinical trial report, Cytomegalovirus Infection Global Clinical Trials Review, Q1, 2011" provides data on the Cytomegalovirus Infection clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Cytomegalovirus Infection. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Cytomegalovirus Infection.

Scope

  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)

Key Topics Covered:

  • Introduction
  • Cytomegalovirus Infection
  • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials by Country
  • Top Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by BRIC Nations
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Cytomegalovirus Infection
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
  • Top Companies Participating in Cytomegalovirus Infection Therapeutics Clinical Trials
  • Prominent Drug Comparison
  • Clinical Trial Profiles

For more information visit http://www.researchandmarkets.com/research/284b61/cytomegalovirus_in



CONTACT:

Research and Markets
Laura Wood, Senior Manager,
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

KEYWORDS:

INDUSTRY KEYWORDS:   Health  Clinical Trials  Infectious Diseases

MEDIA:

Logo
 Logo

Suggested Articles

Gilead Sciences has found a new chief financial officer in an appointment that has mergers and acquisitions written all over it.

Pfizer's role as the hero in ramping up production of a chemo drug badly needed by pediatric oncologists is a turnabout for the drugmaker.

Johnson & Johnson is dealing with $2 billion in patent losses in 2019, but has 10 drugs growing at double-digit percentages, executives said Tuesday.